Percutaneous Needle Electrolysis on Metatarsalgia

November 1, 2022 updated by: Blanca de la Cruz Torres, University of Seville

APPLICATION OF ULTRASOUND-GUIDED PERCUTANEOUS ELECTROLYSIS IN THE PAIN OF THE SECOND METATARSOPHALANGEAL JOINT IN ADULT WOMEN

Percutaneous electrolysis is a minimally invasive method that involves the application of a galvanic current through an acupuncture needle. The needle is placed directly into the soft tissue structures, essential with ultrasound guidance. This technique involves the combination of mechanical stimulation produced by the needle and electrical/biochemical stimulation provided by the electrical current.

Endogenous pain modulation shows clinical relevance of this technique and plays an important role in the experience of pain.

Plantar plate injury is a pathology that frequently occurs in the forefoot, especially in middle-aged women, causing metatarsalgia that is sometimes very intense. In most cases it is secondary to a mechanical imbalance of the forefoot, related to an insufficiency of the first radius. For this reason, the researchers hypothesize that the application of ultrasound-guided percutaneous electrolysis on the plantar plate, combined with the conservative treatment consisting of the development of a personalized plantar orthosis, can cause positive effects in the patient's clinic as well as improve their quality of life.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Blanca De la Cruz Torres, Dr
  • Phone Number: 666676870
  • Email: bcruz@us.es

Study Locations

      • Seville, Spain
        • Recruiting
        • Blanca de la Cruz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Adult female patients (40-65 years old)
  • Having pain in the 2nd MTP joint of the foot due to pathology of the plantar plate, diagnosed by a specialized professional.

Exclusion Criteria:

  • to have suffered an injury to their musculoskeletal system in the last 6 months.
  • to have the present neuritic pathology,
  • to have complete rupture of the plantar plate, 2nd finger supraadductus, flexor digitorum longus tenosynovitis,
  • to have problems in the lumbar spine,
  • to have undergone surgery in the lumbar spine or lower limbs.
  • to use a plantar orthosis.
  • to have the presence of associated pathologies in the foot,
  • to be under the influence of any medication at the time of the study, fear of needles
  • to be pregnant
  • to be epileptic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group I
The subject will obtain a conservative treatment for this type of pathology consisting of the development of a personalized plantar orthosis
Personalized plantar orthosis
Experimental: Group II
The subjects belonging to this group, in addition to providing their corresponding personalized plantar orthosis, will receive a complementary treatment consisting of the application of ultrasound-guided percutaneous electrolysis
Personalized plantar orthosis + percutaneous electrolysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 1 month
Foot Health Status Questionnaire
1 month
Subjetive level of pain
Time Frame: 1 month
Intensity of subjective pain in the injured structure (0, no pain; 10, worse pain)
1 month
level of pain at palpation
Time Frame: 1 month
Intensity of pain on palpation in the injured structure (0, no pain; 10, worse pain)
1 month
Distribution of plantar pressures
Time Frame: 1 month
Podiatric platform (pressure percentage 0-100%)
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

March 1, 2022

Study Completion (Anticipated)

September 30, 2023

Study Registration Dates

First Submitted

February 19, 2022

First Submitted That Met QC Criteria

February 19, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PNE and metatarsalgia

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metatarsalgia

Clinical Trials on Conservatory treatment

3
Subscribe